相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA double-strand breaks induced intractable glomerular fibrosis in renal allografts
Yuki Matsui et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2016)
Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients
Mingzhu Nie et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation
Hong Shen et al.
DRUG METABOLISM AND DISPOSITION (2016)
Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy
Cristina Chimenti et al.
HUMAN PATHOLOGY (2015)
Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease
Bouwien E. Smid et al.
JOURNAL OF MEDICAL GENETICS (2015)
Comparison of in vitro methods for carboxylesterase activity determination in immortalized cells representative of the intestine, liver and kidney
Joana Lamego et al.
MOLECULAR AND CELLULAR PROBES (2015)
DNA damage in Fabry patients: An investigation of oxidative damage and repair
Giovana Brondani Biancini et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2015)
Fibrosis: a key feature of Fabry disease with potential therapeutic implications
Frank Weidemann et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy
Giovana B. Biancini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Oxidatively induced DNA damage: Mechanisms, repair and disease
Miral Dizdaroglu
CANCER LETTERS (2012)
Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy
Marielle J. van Breemen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy
Maria D. Sanchez-Nino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease
S. M. Rombach et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Plasma globotriaosylsphingosine as a biomarker of Fabry disease
Tadayasu Togawa et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Mechanism of oxidative DNA damage in diabetes - tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2'-deoxyguanosine-DNA glycosylase
Simona Simone et al.
DIABETES (2008)
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells
Jin-Song Shen et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults
Alberto Ortiz et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms
Balasubramaniem Ashokkumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
分享论文
